Lovisa Afzelius
General Partner at Flagship Pioneering
Belmont, Massachusetts
Overview
Work Experience
General Partner
2023 - Current
Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability. Since its launch in 2000, the firm has applied a unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $25 billion in aggregate value
Origination Partner
2020 - 2024
Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.
Founding CEO & Director
2020
Alltrna is the creator of a tRNA platform that aims to decipher tRNA biology and pioneer therapies for disease treatment.
Raised $159,000,000.00 from Flagship Pioneering.
Co-founder & CEO
2020
Apriori Bio offers a platform for creating variant-resilient vaccines and provides real-time insights to prepare for future outbreaks.
Raised $51,100,000.00 from Coalition for Epidemic Preparedness Innovations.
Co-founder & CEO
2021
Metaphore Biotechnologies is a firm that uses biomimicry and machine learning to unlock the revolutionary therapeutic.
Raised $50,000,000.00 from Flagship Pioneering.
Co-founder & CEO
2022
Prologue Medicines creates transformative medicines by systematically discovering and evaluating viral proteins and their unique features.
Raised $50,000,000.00 from Flagship Pioneering.
Board Member | Co-founder
2022
Chairman Of The Board | Co-Founder
2017 - 2022
Board Of Directors
2017
President
2020 - 2021
Senior Vice President
2017 - 2020
Corporate Strategy and Operations Computational Sciences | Legal | Finance | Corporate Strategy | Search & Evaluation | R&D Operations A Flagship Pioneering Company
Repertoire Immune Medicines is a clinical stage biotechnology company.
Raised $257,275,890.00 from Invus, PSP Investments, SoftBank Vision Fund, Flagship Pioneering and Alaska Permanent Fund.
Executive Director, Head of Systems Immunology
2017 - 2017
Leading the computational systems immunology, molecular profiling, cytometry profiling and external alliances groups towards an understanding of immune dysfunction and therapeutic mechanisms in human disease. Clinical Research Project Leader, Phase I/II, Immunology
Head of Computational Precision Medicine, Senior Director, Inflammation & Immunology RU
2015 - 2017
Predictive modeling for patient stratification, disease baseline and target validation Clinical Research Project Leader - Autoimmune diseases
Senior Director , Immunoscience RU
2013 - 2015
Clinical Research Project Leader - Autoimmune diseases
Pfizer is a biopharmaceutical company that provides affordable access to safe, effective medicines and health care services.
Raised $32,000,000,000.00 from Starboard Value.
Education
Executive MBA
2014 - 2016
Doctoral
2001 - 2004